TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
KURA

Kura Oncology Inc

Healthcare · Biotechnology

11.00$ -5.9% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement KURA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – – – +25.2%
– -16.3% +55.0% -3.2% -66.7% – – +187.6% +36.0% +11.9% -0.1% -93.3%
– – – – – – – – – – – +25.1%
– +120.9% +14.8% +29.5% +77.0% +2.2% +26.3% +40.3% +9.6% +24.2% +47.5% +47.7%
– +58.3% +30.8% +21.2% +66.8% +22.1% +59.3% +48.6% +1.1% +7.5% +52.5% +55.6%
– +118.9% +18.9% +27.2% +74.3% +7.3% +35.9% +43.1% +6.6% +17.9% +49.8% +50.2%
– – – – – – – – – – – –
– +1,397.4% +555.7% +53.9% +9.2% -40.2% -0.3% -28.4% -44.7% +576.4% +4.5% -6.6%
– – – – – – – – – – – –
– -107.4% – – – -244.4% – – – – – -85.3%
– – – – – – – – – – – –
– – – – – – – – – – – –

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?